$RAPT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in RAPT Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in RAPT Therapeutics, Inc.. Get notifications about new insider transactions in RAPT Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2021 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Option Exercise | A | 19.30 | 7,500 | 144,750 | 7,500 | ||
Jun 24 2021 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Option Exercise | A | 19.30 | 7,500 | 144,750 | 7,500 | ||
Jun 24 2021 | RAPT | RAPT Therapeutics, ... | Svennilson Peter | Option Exercise | A | 19.30 | 7,500 | 144,750 | 7,500 | ||
Jun 17 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 43.26 | 1,000 | 43,260 | 59,529 | 60.5 K to 59.5 K (-1.65 %) |
Jun 16 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 40.00 | 2,000 | 80,000 | 60,529 | 62.5 K to 60.5 K (-3.20 %) |
Jun 15 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Option Exercise | M | 6.18 | 2,647 | 16,358 | 35,580 | |
Jun 15 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Sell | S | 18.55 | 2,647 | 49,102 | 19,812 | 22.5 K to 19.8 K (-11.79 %) |
Jun 15 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Buy | M | 6.18 | 2,647 | 16,358 | 22,459 | 19.8 K to 22.5 K (+13.36 %) |
Jun 02 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 19.50 | 1,000 | 19,500 | 62,529 | 63.5 K to 62.5 K (-1.57 %) |
May 13 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Option Exercise | M | 6.18 | 2,648 | 16,365 | 38,227 | |
May 13 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Sell | S | 18.19 | 2,648 | 48,167 | 19,812 | 22.5 K to 19.8 K (-11.79 %) |
May 13 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Buy | M | 6.18 | 2,648 | 16,365 | 22,460 | 19.8 K to 22.5 K (+13.37 %) |
May 06 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Sell | S | 21.56 | 2,084 | 44,931 | 19,812 | 21.9 K to 19.8 K (-9.52 %) |
May 05 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 22.04 | 1,000 | 22,040 | 64,529 | 65.5 K to 64.5 K (-1.53 %) |
Apr 16 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 21.14 | 1,000 | 21,140 | 63,445 | 64.4 K to 63.4 K (-1.55 %) |
Apr 14 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 19.40 | 300 | 5,820 | 6,100 | 5.8 K to 6.1 K (+5.17 %) | |
Apr 14 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 19.50 | 400 | 7,800 | 5,800 | 5.4 K to 5.8 K (+7.41 %) | |
Apr 13 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 21.09 | 500 | 10,545 | 1,300 | 800 to 1.3 K (+62.50 %) | |
Apr 13 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 20.95 | 300 | 6,286 | 800 | 500 to 800 (+60.00 %) | |
Apr 13 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 21.24 | 300 | 6,372 | 5,400 | 5.1 K to 5.4 K (+5.88 %) | |
Apr 13 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 21.07 | 74 | 1,559 | 5,100 | 5 K to 5.1 K (+1.47 %) | |
Apr 13 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 21.00 | 100 | 2,100 | 5,026 | 4.9 K to 5 K (+2.03 %) | |
Apr 13 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 20.99 | 21 | 441 | 4,926 | 4.9 K to 4.9 K (+0.43 %) | |
Apr 13 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 20.99 | 79 | 1,658 | 4,905 | 4.8 K to 4.9 K (+1.64 %) | |
Apr 13 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 20.92 | 26 | 544 | 4,826 | 4.8 K to 4.8 K (+0.54 %) | |
Apr 02 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Option Exercise | A | 22.20 | 3,025 | 67,155 | 3,025 | ||
Apr 02 2021 | RAPT | RAPT Therapeutics, ... | Svennilson Peter | Option Exercise | A | 22.20 | 2,229 | 49,484 | 2,229 | ||
Apr 02 2021 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Option Exercise | A | 22.20 | 3,822 | 84,848 | 3,822 | ||
Apr 01 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 22.66 | 1,000 | 22,660 | 64,445 | 65.4 K to 64.4 K (-1.53 %) |
Mar 17 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 21.91 | 1,000 | 21,910 | 65,445 | 66.4 K to 65.4 K (-1.51 %) |
Feb 17 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 21.81 | 1,000 | 21,810 | 67,445 | 68.4 K to 67.4 K (-1.46 %) |
Feb 17 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Option Exercise | M | 6.30 | 8,245 | 51,944 | 5,906 | |
Feb 17 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Option Exercise | M | 6.18 | 1,632 | 10,086 | 3,403 | |
Feb 17 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Sell | S | 21.22 | 9,877 | 209,590 | 19,812 | 29.7 K to 19.8 K (-33.27 %) |
Feb 17 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Buy | M | 6.18 | 1,632 | 10,086 | 29,689 | 28.1 K to 29.7 K (+5.82 %) |
Feb 17 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Buy | M | 6.30 | 8,245 | 51,944 | 28,057 | 19.8 K to 28.1 K (+41.62 %) |
Feb 16 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Gift | G | 0.00 | 300 | 0 | 300 | 0 to 300 | |
Feb 16 2021 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Gift | G | 0.00 | 300 | 0 | 4,800 | 5.1 K to 4.8 K (-5.88 %) | |
Feb 02 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 19.99 | 1,000 | 19,990 | 66,414 | 67.4 K to 66.4 K (-1.48 %) |
Feb 01 2021 | RAPT | RAPT Therapeutics, ... | Wong Brian Russell | President and CEO | Option Exercise | A | 19.53 | 150,000 | 2,929,500 | 150,000 | |
Feb 01 2021 | RAPT | RAPT Therapeutics, ... | Young Rodney KB | Chief Financial Off ... | Option Exercise | A | 19.53 | 60,000 | 1,171,800 | 60,000 | |
Feb 01 2021 | RAPT | RAPT Therapeutics, ... | Lam Karen C | VP, Finance and Con ... | Option Exercise | A | 19.53 | 18,000 | 351,540 | 18,000 | |
Feb 01 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Option Exercise | A | 19.53 | 50,000 | 976,500 | 50,000 | |
Feb 01 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Option Exercise | A | 19.53 | 55,000 | 1,074,150 | 55,000 | |
Jan 15 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 21.05 | 831 | 17,493 | 67,414 | 68.2 K to 67.4 K (-1.22 %) |
Jan 15 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 21.05 | 169 | 3,557 | 68,245 | 68.4 K to 68.2 K (-0.25 %) |
Jan 06 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Sell | S | 19.68 | 1,179 | 23,203 | 17,556 | 18.7 K to 17.6 K (-6.29 %) |
Jan 06 2021 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Sell | S | 19.76 | 821 | 16,225 | 18,735 | 19.6 K to 18.7 K (-4.20 %) |
Jan 04 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 19.75 | 775 | 15,306 | 68,414 | 69.2 K to 68.4 K (-1.12 %) |
Jan 04 2021 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 19.75 | 225 | 4,444 | 69,189 | 69.4 K to 69.2 K (-0.32 %) |
Dec 31 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Option Exercise | M | 6.18 | 9,300 | 57,474 | 45,910 | |
Dec 31 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Buy | M | 6.18 | 9,300 | 57,474 | 19,556 | 10.3 K to 19.6 K (+90.68 %) |
Dec 15 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 24.55 | 795 | 19,517 | 69,414 | 70.2 K to 69.4 K (-1.13 %) |
Dec 15 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 24.55 | 205 | 5,033 | 70,209 | 70.4 K to 70.2 K (-0.29 %) |
Dec 01 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 21.83 | 524 | 11,439 | 70,414 | 70.9 K to 70.4 K (-0.74 %) |
Dec 01 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 21.83 | 476 | 10,391 | 70,938 | 71.4 K to 70.9 K (-0.67 %) |
Dec 01 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 21.83 | 524 | 11,439 | 70,414 | 70.9 K to 70.4 K (-0.74 %) |
Dec 01 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 21.83 | 476 | 10,391 | 70,938 | 71.4 K to 70.9 K (-0.67 %) |
Nov 23 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 16.09 | 500 | 8,045 | 500 | 0 to 500 | |
Nov 23 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 16.08 | 500 | 8,040 | 5,100 | 4.6 K to 5.1 K (+10.87 %) | |
Nov 20 2020 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Buy | P | 16.22 | 10,000 | 162,200 | 18,000 | 8 K to 18 K (+125.00 %) | |
Nov 18 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Option Exercise | M | 6.30 | 5,000 | 31,500 | 11,666 | |
Nov 18 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Option Exercise | M | 6.18 | 3,356 | 20,740 | 4,861 | |
Nov 18 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 20.25 | 1,000 | 20,250 | 71,414 | 72.4 K to 71.4 K (-1.38 %) |
Nov 18 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Buy | M | 6.30 | 5,000 | 31,500 | 72,414 | 67.4 K to 72.4 K (+7.42 %) |
Nov 18 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Buy | M | 6.18 | 3,356 | 20,740 | 67,414 | 64.1 K to 67.4 K (+5.24 %) |
Nov 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Option Exercise | M | 6.30 | 6,508 | 41,000 | 14,151 | |
Nov 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Option Exercise | M | 6.18 | 3,369 | 20,820 | 5,035 | |
Nov 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Sell | S | 17.01 | 9,877 | 168,008 | 10,256 | 20.1 K to 10.3 K (-49.06 %) |
Nov 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Buy | M | 6.30 | 6,508 | 41,000 | 20,133 | 13.6 K to 20.1 K (+47.77 %) |
Nov 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Buy | M | 6.18 | 3,369 | 20,820 | 13,625 | 10.3 K to 13.6 K (+32.85 %) |
Nov 03 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Sell | S | 28.06 | 1,910 | 53,595 | 10,256 | 12.2 K to 10.3 K (-15.70 %) |
Nov 03 2020 | RAPT | RAPT Therapeutics, ... | Lam Karen C | VP, Finance and Con ... | Sell | S | 28.14 | 2,022 | 56,899 | 12,735 | 14.8 K to 12.7 K (-13.70 %) |
Nov 03 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 28.06 | 1,000 | 28,060 | 64,058 | 65.1 K to 64.1 K (-1.54 %) |
Oct 20 2020 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Sell | J | 0.00 | 650,000 | 0 | 1,947,063 | 2.6 M to 1.9 M (-25.03 %) |
Oct 16 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 35.76 | 1,000 | 35,760 | 65,058 | 66.1 K to 65.1 K (-1.51 %) |
Oct 13 2020 | RAPT | RAPT Therapeutics, ... | Wong Brian Russell | President and CEO | Sell | S | 40.05 | 20,000 | 801,040 | 337,000 | 357 K to 337 K (-5.60 %) |
Oct 13 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 40.20 | 2,000 | 80,400 | 66,058 | 68.1 K to 66.1 K (-2.94 %) |
Oct 02 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 31.18 | 1,000 | 31,180 | 68,058 | 69.1 K to 68.1 K (-1.45 %) |
Sep 29 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 28.55 | 200 | 5,710 | 6,550 | 6.4 K to 6.6 K (+3.15 %) | |
Sep 29 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 28.80 | 300 | 8,640 | 6,350 | 6.1 K to 6.4 K (+4.96 %) | |
Sep 29 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 28.55 | 200 | 5,710 | 6,550 | 6.4 K to 6.6 K (+3.15 %) | |
Sep 29 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 28.80 | 300 | 8,640 | 6,350 | 6.1 K to 6.4 K (+4.96 %) | |
Sep 25 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Option Exercise | M | 6.18 | 2,200 | 13,596 | 8,217 | |
Sep 25 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Buy | M | 6.18 | 2,200 | 13,596 | 69,058 | 66.9 K to 69.1 K (+3.29 %) |
Sep 25 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Option Exercise | M | 6.18 | 2,200 | 13,596 | 8,217 | |
Sep 25 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Buy | M | 6.18 | 2,200 | 13,596 | 69,058 | 66.9 K to 69.1 K (+3.29 %) |
Sep 24 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 28.00 | 200 | 5,600 | 6,050 | 5.9 K to 6.1 K (+3.42 %) | |
Sep 24 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 29.50 | 100 | 2,950 | 5,850 | 5.8 K to 5.9 K (+1.74 %) | |
Sep 24 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Buy | P | 29.10 | 300 | 8,730 | 5,750 | 5.5 K to 5.8 K (+5.50 %) | |
Sep 23 2020 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Sell | S | 30.85 | 608,000 | 18,756,800 | 3,835,679 | 4.4 M to 3.8 M (-13.68 %) |
Sep 23 2020 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Sell | S | 30.85 | 608,000 | 18,756,800 | 3,835,679 | 4.4 M to 3.8 M (-13.68 %) |
Sep 23 2020 | RAPT | RAPT Therapeutics, ... | Wong Brian Russell | President and CEO | Buy | P | 30.06 | 2,000 | 60,120 | 357,000 | 355 K to 357 K (+0.56 %) |
Sep 22 2020 | RAPT | RAPT Therapeutics, ... | Svennilson Peter | Director | Sell | S | 30.85 | 608,000 | 18,756,800 | 3,835,679 | 4.4 M to 3.8 M (-13.68 %) |
Sep 15 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 36.14 | 1,000 | 36,140 | 66,858 | 67.9 K to 66.9 K (-1.47 %) |
Sep 11 2020 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Sell | J | 0.00 | 650,000 | 0 | 2,597,063 | 3.2 M to 2.6 M (-20.02 %) |
Sep 02 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 26.24 | 1,000 | 26,240 | 67,858 | 68.9 K to 67.9 K (-1.45 %) |
Aug 19 2020 | RAPT | RAPT Therapeutics, ... | Svennilson Peter | Director | Sell | S | 22.75 | 538,654 | 12,254,379 | 4,443,679 | 5 M to 4.4 M (-10.81 %) |
Aug 19 2020 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Sell | S | 22.75 | 538,654 | 12,254,379 | 4,443,679 | 5 M to 4.4 M (-10.81 %) |
Aug 18 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 24.76 | 1,000 | 24,760 | 68,858 | 69.9 K to 68.9 K (-1.43 %) |
Aug 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Option Exercise | M | 6.18 | 9,877 | 61,040 | 58,579 | |
Aug 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Sell | S | 24.07 | 8,375 | 201,586 | 10,256 | 18.6 K to 10.3 K (-44.95 %) |
Aug 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Sell | S | 23.13 | 1,502 | 34,741 | 18,631 | 20.1 K to 18.6 K (-7.46 %) |
Aug 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Buy | M | 6.18 | 9,877 | 61,040 | 20,133 | 10.3 K to 20.1 K (+96.30 %) |
Aug 03 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 21.54 | 1,000 | 21,540 | 69,858 | 70.9 K to 69.9 K (-1.41 %) |
Jul 27 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Director | Buy | P | 22.75 | 400 | 9,100 | 5,450 | 5.1 K to 5.5 K (+7.92 %) |
Jul 27 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Director | Buy | P | 22.25 | 500 | 11,125 | 5,050 | 4.6 K to 5.1 K (+10.99 %) |
Jul 16 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 28.76 | 1,000 | 28,760 | 70,858 | 71.9 K to 70.9 K (-1.39 %) |
Jul 16 2020 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Sell | J | 0.00 | 300,000 | 0 | 3,247,063 | 3.5 M to 3.2 M (-8.46 %) |
Jul 16 2020 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Sell | J | 0.00 | 300,000 | 0 | 3,247,063 | 3.5 M to 3.2 M (-8.46 %) |
Jul 01 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 28.61 | 1,000 | 28,610 | 71,858 | 72.9 K to 71.9 K (-1.37 %) |
Jul 01 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Director | Buy | P | 26.30 | 500 | 13,150 | 4,550 | 4.1 K to 4.6 K (+12.35 %) |
Jul 01 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Director | Buy | P | 26.50 | 500 | 13,250 | 4,050 | 3.6 K to 4.1 K (+14.08 %) |
Jul 01 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Director | Buy | P | 25.77 | 1,600 | 41,232 | 3,550 | 2 K to 3.6 K (+82.05 %) |
Jun 26 2020 | RAPT | RAPT Therapeutics, ... | Giordano Michael F | Director | Option Exercise | M | 12.00 | 8,944 | 107,328 | 6,390 | |
Jun 26 2020 | RAPT | RAPT Therapeutics, ... | Giordano Michael F | Director | Option Exercise | M | 6.18 | 10,069 | 62,226 | 6,597 | |
Jun 26 2020 | RAPT | RAPT Therapeutics, ... | Giordano Michael F | Director | Sell | S | 33.37 | 19,013 | 634,464 | 0 | 19 K to 0 (-100.00 %) |
Jun 26 2020 | RAPT | RAPT Therapeutics, ... | Giordano Michael F | Director | Buy | M | 12.00 | 8,944 | 107,328 | 8,944 | 0 to 8.9 K |
Jun 26 2020 | RAPT | RAPT Therapeutics, ... | Giordano Michael F | Director | Buy | M | 6.18 | 10,069 | 62,226 | 10,069 | 0 to 10.1 K |
Jun 26 2020 | RAPT | RAPT Therapeutics, ... | Lam Karen C | VP, Finance & Contr ... | Sell | S | 35.00 | 875 | 30,625 | 12,735 | 13.6 K to 12.7 K (-6.43 %) |
Jun 22 2020 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | J | 28.27 | 22,500 | 636,075 | 22,500 | |
Jun 19 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Director | Option Exercise | A | 28.27 | 7,500 | 212,025 | 7,500 | |
Jun 19 2020 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Director | Option Exercise | A | 28.27 | 7,500 | 212,025 | 7,500 | |
Jun 19 2020 | RAPT | RAPT Therapeutics, ... | Kozick Linda | Director | Option Exercise | A | 28.27 | 7,500 | 212,025 | 7,500 | |
Jun 19 2020 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Director | Option Exercise | A | 28.27 | 7,500 | 212,025 | 7,500 | |
Jun 19 2020 | RAPT | RAPT Therapeutics, ... | Giordano Michael F | Director | Option Exercise | A | 28.27 | 7,500 | 212,025 | 7,500 | |
Jun 19 2020 | RAPT | RAPT Therapeutics, ... | Svennilson Peter | Director | Option Exercise | A | 28.27 | 22,500 | 636,075 | 22,500 | |
Jun 18 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 20.95 | 1,000 | 20,950 | 72,858 | 73.9 K to 72.9 K (-1.35 %) |
Jun 02 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 18.50 | 1,000 | 18,500 | 73,858 | 74.9 K to 73.9 K (-1.34 %) |
May 29 2020 | RAPT | RAPT Therapeutics, ... | Topspin Fund L.P. | 10% Owner | Sell | S | 0.00 | 2,056,666 | 0 | 559,243 | 2.6 M to 559.2 K (-78.62 %) |
May 22 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Sell | S | 18.02 | 7,500 | 135,150 | 74,858 | 82.4 K to 74.9 K (-9.11 %) |
May 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Option Exercise | M | 6.18 | 9,877 | 61,040 | 68,456 | |
May 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Sell | S | 15.00 | 9,877 | 148,155 | 10,256 | 20.1 K to 10.3 K (-49.06 %) |
May 18 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Buy | M | 6.18 | 9,877 | 61,040 | 20,133 | 10.3 K to 20.1 K (+96.30 %) |
May 13 2020 | RAPT | RAPT Therapeutics, ... | Lam Karen C | VP, Finance & Contr ... | Option Exercise | M | 1.86 | 2,777 | 5,165 | 5,556 | |
May 13 2020 | RAPT | RAPT Therapeutics, ... | Lam Karen C | VP, Finance & Contr ... | Buy | M | 1.86 | 2,777 | 5,165 | 13,610 | 10.8 K to 13.6 K (+25.63 %) |
May 08 2020 | RAPT | RAPT Therapeutics, ... | Lam Karen C | VP, Finance & Contr ... | Sell | S | 15.40 | 1,831 | 28,197 | 10,833 | 12.7 K to 10.8 K (-14.46 %) |
Apr 02 2020 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Director | Option Exercise | A | 21.27 | 3,984 | 84,740 | 3,984 | |
Apr 02 2020 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Director | Option Exercise | A | 21.27 | 3,154 | 67,086 | 3,154 | |
Jan 31 2020 | RAPT | RAPT Therapeutics, ... | Wong Brian Russell | President and CEO | Option Exercise | A | 44.66 | 60,000 | 2,679,600 | 60,000 | |
Jan 31 2020 | RAPT | RAPT Therapeutics, ... | Wong Brian Russell | President and CEO | Grant | A | 0.00 | 22,000 | 0 | 147,000 | 125 K to 147 K (+17.60 %) |
Jan 31 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Option Exercise | A | 44.66 | 20,000 | 893,200 | 20,000 | |
Jan 31 2020 | RAPT | RAPT Therapeutics, ... | Brockstedt Dirk G. | Chief Scientific Of ... | Grant | A | 0.00 | 8,000 | 0 | 8,000 | 0 to 8 K |
Jan 31 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Option Exercise | A | 44.66 | 20,000 | 893,200 | 20,000 | |
Jan 31 2020 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Grant | A | 0.00 | 8,000 | 0 | 80,223 | 72.2 K to 80.2 K (+11.08 %) |
Jan 31 2020 | RAPT | RAPT Therapeutics, ... | Lam Karen C | VP, Finance & Contr ... | Option Exercise | A | 44.66 | 7,500 | 334,950 | 7,500 | |
Jan 31 2020 | RAPT | RAPT Therapeutics, ... | Lam Karen C | VP, Finance & Contr ... | Grant | A | 0.00 | 2,500 | 0 | 10,833 | 8.3 K to 10.8 K (+30.00 %) |
Dec 06 2019 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Director | Option Exercise | A | 27.53 | 22,500 | 619,425 | 22,500 | |
Dec 04 2019 | RAPT | RAPT Therapeutics, ... | Young Rodney KB | Chief Financial Off ... | Option Exercise | A | 21.73 | 140,000 | 3,042,200 | 140,000 | |
Nov 15 2019 | RAPT | RAPT Therapeutics, ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 155,201 | 0 | 0 |